215 related articles for article (PubMed ID: 15339339)
1. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
2. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.
Klaes R; Friedrich T; Spitkovsky D; Ridder R; Rudy W; Petry U; Dallenbach-Hellweg G; Schmidt D; von Knebel Doeberitz M
Int J Cancer; 2001 Apr; 92(2):276-84. PubMed ID: 11291057
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical detection of p16INK4a protein in scraped cervical cells.
Pientong C; Ekalaksananan T; Swadpanich U; Kongyingyoes B; Kritpetcharat O; Yuenyao P; Ruckait N
Acta Cytol; 2003; 47(4):616-23. PubMed ID: 12920756
[TBL] [Abstract][Full Text] [Related]
7. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens.
Bibbo M; Klump WJ; DeCecco J; Kovatich AJ
Acta Cytol; 2002; 46(1):25-9. PubMed ID: 11843554
[TBL] [Abstract][Full Text] [Related]
8. Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples.
Trunk MJ; Dallenbach-Hellweg G; Ridder R; Petry KU; Ikenberg H; Schneider V; von Knebel Doeberitz M
Acta Cytol; 2004; 48(6):771-82. PubMed ID: 15581161
[TBL] [Abstract][Full Text] [Related]
9. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
[TBL] [Abstract][Full Text] [Related]
10. P16INK4A as an adjunct test in liquid-based cytology.
Bibbo M; DeCecco J; Kovatich AJ
Anal Quant Cytol Histol; 2003 Feb; 25(1):8-11. PubMed ID: 12630076
[TBL] [Abstract][Full Text] [Related]
11. [Expression of the protein marker p16INK4a in the cervix uteri cancer].
Volgareva GM; Zavalishina LE; Frank GA; Andreeva IuIu; Petrov AN; Kiselev FL; Spitkovskiĭ DD
Arkh Patol; 2002; 64(1):22-4. PubMed ID: 11889694
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
[TBL] [Abstract][Full Text] [Related]
13. Potential diagnostic value of P16 expression in premalignant and malignant cervical lesions.
Izadi-Mood N; Asadi K; Shojaei H; Sarmadi S; Ahmadi SA; Sani S; Chelavi LH
J Res Med Sci; 2012 May; 17(5):428-33. PubMed ID: 23626605
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
[TBL] [Abstract][Full Text] [Related]
15. [P16NIK4a expression in premalignant cervical lesions].
Bolanca IK; Simon SK; Sentija K; Duić Z; Kukura V; Zovko G; Valetić J; Vranes J
Acta Med Croatica; 2011 Sep; 65 Suppl 1():53-8. PubMed ID: 23126030
[TBL] [Abstract][Full Text] [Related]
16. p16INK4a immunohistochemical and histopathologic study of Pap test cases interpreted as HSIL without CIN2-3 identification in subsequent cervical specimens.
Solano FJ; Rush DS; Wilkinson EJ
Int J Gynecol Pathol; 2015 May; 34(3):215-20. PubMed ID: 25844545
[TBL] [Abstract][Full Text] [Related]
17. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.
Feng W; Xiao J; Zhang Z; Rosen DG; Brown RE; Liu J; Duan X
Mod Pathol; 2007 Sep; 20(9):961-6. PubMed ID: 17632454
[TBL] [Abstract][Full Text] [Related]
18. [Cell protein p16INK4a hyperexpression in epithelial malignancies induced by human papillomaviruses].
Volgareva GM; Zavalishina LE; Andreeva IuIu; Shtil' AA; Frank GA
Arkh Patol; 2008; 70(5):57-61. PubMed ID: 19137788
[TBL] [Abstract][Full Text] [Related]
19. [Expression of human papilloma virus (HPV) and P16ink4a in cervical intraepithelial neoplasia (CIN) and papilloma].
Vasilev I; Gŭlŭbova M; Velev V; Buzalov S; Todorova M; Stratiev S; Stoianov S
Akush Ginekol (Sofiia); 2006; 45(1):27-31. PubMed ID: 16637315
[TBL] [Abstract][Full Text] [Related]
20. p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.
Murphy N; Heffron CC; King B; Ganuguapati UG; Ring M; McGuinness E; Sheils O; O'Leary JJ
Virchows Arch; 2004 Dec; 445(6):610-5. PubMed ID: 15378361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
